|
1
|
Burris HA III and Hurtig J: Radiation
recall with anticancer agents. Oncologist. 15:1227–1237. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shanholtz C: Acute life-threatening
toxicity of cancer treatment. Crit Care Clin. 17:483–502. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Doi M, Okamoto Y, Yamauchi M, Naitou H and
Shinozaki K: Bleomycin-induced pulmonary fibrosis after tumor lysis
syndrome in a case of advanced yolk sac tumor treated with
bleomycin, etoposide and cisplatin (BEP) chemotherapy. Int J Clin
Oncol. 17:528–531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Forschner A, Zips D, Schraml C, Röcken M,
Iordanou E, Leiter U, Weide B, Garbe C and Meier F: Radiation
recall dermatitis and radiation pneumonitis during treatment with
vemurafenib. Melanoma Res. 24:512–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brunello A, Rizzato MD, Rastrelli M, Roma
A, Maruzzo M, Basso U, Fiduccia P, Buzzaccarini MS, Scarzello G,
Rossi CR, et al: Adjuvant chemotherapy for soft tissue sarcomas: A
10-year mono-institutional experience. J Cancer Res Clin Oncol.
142:679–685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanaka K, Mizusawa J, Fukuda H, Araki N,
Chuman H, Takahashi M, Ozaki T, Hiruma T, Tsuchiya H, Morioka H, et
al: Perioperative chemotherapy with ifosfamide and doxorubicin for
high-grade soft tissue sarcomas in the extremities (JCOG0304). Jpn
J Clin Oncol. 45:551–561. 2015.
|
|
7
|
Baker WJ, Fistel SJ, Jones RV and Weiss
RB: Interstitial pneumonitis associated with ifosfamide therapy.
Cancer. 65:2217–2221. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Prestwich RJ, Picton SV, Glaser A and
Taylor RE: Fatal pneumonitis in children with metastatic
rhabdomyosarcoma following whole lung radiotherapy and sequential
epirubicin. Pediatr Blood Cancer. 48:586–590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dincol D, Buyukcelik A, Dogan M, Akbulut
H, Samur M, Demirkazik A, Senler FC, Onur H and Icli F: Long-term
outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE)
regimen as a consolidation in patients with aggressive non-Hodgkin
lymphoma responding to CHOP. Med Oncol. 27:942–945. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arakawa H, Johkoh T, Sakai F, Kusumoto M,
Hataji O and Taguchi O: Exacerbation of radiation fibrosis with
erlotinib: Another pattern of radiation recall phenomenon. Jpn J
Radiol. 29:587–589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma LD, Taylor GA, Wharam MD and Wiley JM:
‘Recall’ pneumonitis: Adriamycin potentiation of radiation
pneumonitis in two children. Radiology. 187:465–467. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Minami-Shimmyo Y, Ohe Y, Yamamoto S, Sumi
M, Nokihara H, Horinouchi H, Yamamoto N, Sekine I, Kubota K and
Tamura T: Risk factors for treatment-related death associated with
chemotherapy and thoracic radiotherapy for lung cancer. J Thorac
Oncol. 7:177–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fox AM, Dosoretz AP, Mauch PM, Chen YH,
Fisher DC, LaCasce AS, Freedman AS, Silver B and Ng AK: Predictive
factors for radiation pneumonitis in Hodgkin lymphoma patients
receiving combined-modality therapy. Int J Radiat Oncol Biol Phys.
83:277–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Azria D, Magné N, Zouhair A, Castadot P,
Culine S, Ychou M, Stupp R, Van Houtte P, Dubois JB and Ozsahin M:
Radiation recall: A well recognized but neglected phenomenon.
Cancer Treat Rev. 31:550–570. 2005. View Article : Google Scholar
|
|
15
|
Schweitzer VG, Juillard GJ, Bajada CL and
Parker RG: Radiation recall dermatitis and pneumonitis in a patient
treated with paclitaxel. Cancer. 76:1069–1072. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding X, Ji W, Li J, Zhang X and Wang L:
Radiation recall pneumonitis induced by chemotherapy after thoracic
radiotherapy for lung cancer. Radiat Oncol. 6:242011. View Article : Google Scholar : PubMed/NCBI
|
